Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Long-lasting symptoms like fatigue and breathlessness can persist after COVID-19, requiring ongoing medical follow-up.

ISX9 helps regrow hair by activating a specific cell signaling pathway.

New methods for identifying and managing polycystic ovary syndrome in teenagers are improving.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

Low ferritin, vitamin D deficiency, and thyroid problems may contribute to hair loss in some hospital patients in Western Saudi Arabia.

Sodium valproate is not recommended as a first-line treatment for neuropathy but may be used in resistant cases.

The cryogel effectively heals infected wounds and promotes tissue regeneration without scarring.

Digital health platforms improve treatment for male pattern hair loss.

Vitamin D3 helps treat mild to moderate alopecia areata, especially when combined with other treatments.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Adipose-derived stem cells are promising for regenerative medicine due to their accessibility, versatility, and low risk of immune rejection.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

CD34+ and CD34- melanocyte stem cells have different regenerative abilities.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

TRPV channels are important in osteoarthritis and could be key to new treatments.

Female representation in dermatology is stable, but minority representation is low and needs improvement.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Drug repositioning can save time and money but needs more support.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Tirzepatide users experience more hair loss than semaglutide users.

New regenerative treatments show promise in improving hair growth for androgenetic alopecia.

Hangeshashinto's natural products may help treat stomatitis by reducing inflammation and cytotoxicity.

Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.

Cells lacking the Bax protein can outcompete others, leading to better tissue repair and hair growth.

Hair follicle sampling is a practical method for measuring biomarkers in children with and without Fragile X syndrome.

Further research is needed to develop effective cancer prevention strategies.

Reducing nerve growth can help skin regenerate after birth.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.